Pneumovax 23 (pneumococcal vaccine polyvalent) NDC 0006-4837

NDC codes

FDA NDC Directory

Product NDC (as listed)0006-4837Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00006-4837Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0006-4837-03	00006483703	10 SYRINGE, GLASS in 1 CARTON (0006-4837-03) / .5 mL in 1 SYRINGE, GLASS (0006-4837-01)Marketed from Jul 21, 2014

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pneumovax 23
Generic name (nonproprietary): pneumococcal vaccine polyvalent
Active ingredients: Streptococcus pneumoniae type 1 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 2 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 3 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 4 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 5 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 6b capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 7f capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 8 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 9n capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 9v capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 10a capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 11a capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 12f capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 14 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 15b capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 17f capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 18c capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 19f capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 19a capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 20 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 22f capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 23f capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 33f capsular polysaccharide antigen — 25 ug/.5mL
Dosage form: Injection, Solution
Route: Intramuscular, Subcutaneous
Labeler: Merck Sharp & Dohme LLC
Product type: Vaccine
Marketing category: BLA — Biologics License ApplicationApplication BLA 101094
Marketing start: Jul 21, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)
Identifiers: Product ID 0006-4837_34f422ac-b31a-43fa-abd3-b5707327a8cdSPL ID 34f422ac-b31a-43fa-abd3-b5707327a8cd
Pharmacologic class: Inactivated Pneumococcal Vaccine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N400006483703 followed by a unit qualifier and the quantity

Package 00006-4837-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 101094

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 101094
Product	Strength	Form · route	Labeler	Product NDC
Pneumovax 23pneumococcal vaccine polyvalent	Streptococcus pneumoniae type 1 capsular polysaccharide antigen 25 ug/.5mL + 22 more ingredients	Injection, SolutionIntramuscular, Subcutaneous	Merck Sharp & Dohme LLC	0006-4943